Endoplasmic reticulum proteostasis impairment in aging
Author
dc.contributor.author
Martínez Bravo, Gabriela
Author
dc.contributor.author
Durán Aniotz, Claudia
Author
dc.contributor.author
Cabral Miranda, Felipe
Author
dc.contributor.author
Vivar, Juan P.
Author
dc.contributor.author
Hetz Flores, Claudio
Admission date
dc.date.accessioned
2019-01-29T14:12:22Z
Available date
dc.date.available
2019-01-29T14:12:22Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Aging Cell (2017) 16, pp. 615–623
Identifier
dc.identifier.issn
14749726
Identifier
dc.identifier.issn
14749718
Identifier
dc.identifier.other
10.1111/acel.12599
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160193
Abstract
dc.description.abstract
Perturbed neuronal proteostasis is a salient feature shared by both aging and protein misfolding disorders. The proteostasis network controls the health of the proteome by integrating pathways involved in protein synthesis, folding, trafficking, secretion, and their degradation. A reduction in the buffering capacity of the proteostasis network during aging may increase the risk to undergo neurodegeneration by enhancing the accumulation of misfolded proteins. As almost one-third of the proteome is synthetized at the endoplasmic reticulum (ER), maintenance of its proper function is fundamental to sustain neuronal function. In fact, ER stress is a common feature of most neurodegenerative diseases. The unfolded protein response (UPR) operates as central player to maintain ER homeostasis or the induction of cell death of chronically damaged cells. Here, we discuss recent evidence placing ER stress as a driver of brain aging, and the emerging impact of neuronal UPR in controlling global proteostasis at the whole organismal level. Finally, we discuss possible therapeutic interventions to improve proteostasis and prevent pathological brain aging.